Skip to main content

Nasdaq IPOs

Roth Capital's SPAC Roth CH Acquisition files for a $75 million IPO

6 years 7 months ago
Roth CH Acquisition, a blank check company formed by executives Roth Capital and Craig-Hallum Capital, filed on Tuesday with the SEC to raise up to $75 million in an initial public offering. The Newport Beach, CA-based company plans to raise $75 million by offering 7.5 million u
Renaissance Capital

Genetic disorder biotech Imara sets terms for $76 million IPO

6 years 7 months ago
Imara, a Phase 2 biotech developing small molecule therapies for rare genetic disorders, announced terms for its IPO on Tuesday. The Boston, MA-based company plans to raise $76 million by offering 4.5 million shares at a price range of $16 to $18. At the midpoint of the proposed
Renaissance Capital

Wave of IPOs file in spite of market turmoil

6 years 7 months ago
A wave of 6 IPOs and 5 SPACs submitted initial filings over the past week, despite the stock market having its worst week since 2008. Most filed on Friday, meaning they will be able to launch as soon as Monday, March 16, and schedule IPOs for the last week of March. During peri
Renaissance Capital

Cannabis SPAC Collective Growth Corp files for a $150 million IPO

6 years 7 months ago
Collective Growth Corp, a blank check company targeting the cannabis industry, announced terms for its IPO on Monday. The Austin, TX-based company plans to raise $150 million by offering 15 million units at a price of $10. Each unit consists of one Class A share and one half of
Renaissance Capital

Growth-focused SPAC Live Oak Acquisition files for a $200 million IPO

6 years 7 months ago
Live Oak Acquisition, a blank check company targeting a high-growth business with strong cash flow, filed on Monday with the SEC to raise up to $200 million in an initial public offering. The Great Falls, VA-based company plans to raise $200 million by offering 20 million units
Renaissance Capital

US IPO Week Ahead: Waste giant GFL recycles its billion-dollar IPO

6 years 7 months ago
As the IPO market reels from the effects of the coronavirus, just one billion-dollar deal is scheduled for the week ahead, following a 9% drop in the Renaissance IPO Index and the largest spike in the VIX volatility index since Black Monday 2011.GFL Environmental (GFL), North Am
Renaissance Capital

IPO Weekly Recap: Yes, the IPO Market has caught the coronavirus

6 years 7 months ago
The IPO market is feeling the effects of the coronavirus outbreak with a surge in the VIX volatility index weighing on IPO activity. Since 2015, a week in which VIX volatility has surpassed 35 has been followed by a week averaging two US IPO pricings. Our observational trend con
Renaissance Capital

Preclinical CNS biotech NLS Pharmaceutics files for a $40 million IPO

6 years 7 months ago
NLS Pharmaceutics, an early-stage biotech focusing on therapies for CNS and sleep disorders, filed on Friday with the SEC to raise up to $40 million in an initial public offering. The Stans, Switzerland-based company was founded in 2015 and plans to list on the Nasdaq under the
Renaissance Capital

Health benefits platform Accolade files for a $100 million IPO

6 years 7 months ago
Accolade, which provides a platform that helps employees manage their healthcare benefits, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Seattle, WA-based company was founded in 2007 and booked $123 million in sales for the 12 months
Renaissance Capital

Oncology biotech ORIC Pharmaceuticals files for an $86 million IPO

6 years 7 months ago
ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for cancer, filed on Friday with the SEC to raise up to $86 million in an initial public offering. The South San Francisco, CA-based company was founded in 2014 and plans to list on the Nasdaq under the
Renaissance Capital
Checked
23 minutes 17 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed